PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study

INTRODUCTION: Osilodrostat decreases cortisol production by inhibiting 11β-hydroxylase, which increases adrenal hormones proximal to the blockade. Here, we describe these effects of osilodrostat and associated adverse events (AEs). The efficacy and safety of osilodrostat in patients with Cushing...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Biller, Beverly M K, Shimatsu, Akira, Newell-Price, John, Tabarin, Antoine, Vila, Greisa, Piacentini, Andrea, Pedroncelli, Alberto M, Pivonello, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625140/
http://dx.doi.org/10.1210/jendso/bvac150.1136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625140/
http://dx.doi.org/10.1210/jendso/bvac150.1136

Ejemplares similares